Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 89,145

Document Document Title
WO/2016/082050A1
The invention relates to a novel cell-free liquid culture medium which allows the growth of the bacterium Piscirickettsia salmonis in a minimum period of time, by means of the nutritional supply of defined minimum components with concent...  
WO/2016/083450A2
The present invention relates to a new probiotic with immune modulating properties and to a new biomarker.  
WO/2016/083397A1
The present invention relates to genes conferring acetic acid tolerance in yeast. More specifically, the invention relates to the use of DOT5, preferably in combination with CUP2 and/or HAA1 to obtain acid tolerance in yeast. Even more p...  
WO/2016/084880A1
The purpose of the present invention is to obtain a PCNA mutant having excellent DNA polymerase amplification-enhancing activity in DNA replication. Markedly excellent DNA polymerase amplification-enhancing activity is achieved in DNA re...  
WO/2016/083996A1
There is provided a method of treating hay for preventing and/or reducing heat damage in high moisture hay and as well to preserve the same, the method comprising adding to hay a hay preservative comprising a hay preserving and heat redu...  
WO/2016/083617A1
The present invention relates to an improved method for preservation of e.g. microorganisms, especially lactic acid bacteria, said method includes spray freezing.  
WO/2016/080510A1
The present invention addresses the problem of providing a novel format of a bispecific antibody which retains high binding capacity to both antigens and can be efficiently produced in a commercial production process. As a bispecific ant...  
WO/2016/080371A1
Provided is a method for obtaining a lactic acid bacterium having a property of reducing a serum uric acid level. The present invention relates to: a method for screening for a lactic acid bacterium, which comprises determining the amoun...  
WO/2016/080549A1
A novel enzyme capable of isomerizing (Z)-3-hexenal into (E)-2-hexenal, said enzyme comprising a polypeptide containing amino acid sequence (A) selected from amino acid sequence (A1) represented by any of SEQ ID NOS:1-5 and SEQ ID NOS:35...  
WO/2016/079305A1
The present invention relates to alpha-amylase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using t...  
WO/2016/081239A1
The invention relates to a composition and methods for remediation of sulfate reducing bacteria (SRB) with newly discovered broad range bacteriocin recovered from oil and gas operation waste waters.  
WO/2016/078466A1
The present invention provides a method for preparing an influenza virus hemagglutinin glycoprotein having a mammal sugar-type structure and no fucose. The method comprises: making influenza virus hemagglutinin HA gene express in a yeast...  
WO/2016/080430A1
Provided is a means for constructing a composite material wherein a functional structure or inorganic material is combined with an organic material. More specifically, provided are: a peptide such as a peptide containing an amino acid se...  
WO/2016/079568A1
The invention describes an easy manufacturing culture medium obtained from the avocado seed for the growth and support of microalgae, fungi, yeasts, moss, bacteria and plants.  
WO/2016/080448A1
Provided is a novel preventive and therapeutic agent for celiac disease. The preventive and therapeutic agent for celiac disease includes, as an active ingredient: one or more bacteria belonging to Bifidobacterium sp. selected from Bifid...  
WO/2016/081704A1
Described herein are plasmid addiction systems comprising a host cell comprising one or more inactivated host cell essential genes; and a plasmid comprising one or more plasmid essential genes operably linked to a constitutively active p...  
WO/2016/075243A1
The present invention relates to a method to produce mutated microorganisms which resist the phenomenon of lactose killing and to the microorganisms obtainable via said method. Such engineered microorganisms can be applied for the produc...  
WO/2016/075312A1
The invention relates to a set of tools and methods allowing the simple and rapid production of a large number of expression vectors for expressing proteins of interest in oleaginous yeasts, in particular Yarrowia lipolytica.  
WO/2016/076231A1
[Problem] To provide a method for producing a lipid, said method improving productivity for a medium-chain fatty acid or a lipid having said fatty acid as a constituent. [Solution] Provided is a method for producing a lipid whereby a tra...  
WO/2016/076317A1
An agent for preserving a biological component, the agent including a hydrogel, wherein the hydrogel includes a crosslinked product formed from a compound having a plurality of hydroxyl groups and a modified hyaluronic acid having substi...  
WO/2016/076454A1
The present invention relates to a method for producing 9-cis β-carotene from microorganisms, comprising a method for improving the culture rate of microorganisms using a photochemical gas generated by the micro-spray of gas and the con...  
WO/2016/077067A2
Disclosed herein is an improved method for magnetic capture of target molecules (e.g., microbes) in a fluid. Kits and solid substrates for carrying the method described herein are also provided. In some embodiments, the methods, kits, an...  
WO/2016/076364A1
Provided is flavin-binding glucose dehydrogenase having high substrate specificity for D-glucose, as well as low reactivity with D-xylose. A flavin-binding glucose dehydrogenase having a substitution of one or more amino acid residues at...  
WO/2016/074221A1
Provided are a spinosad heterologous expression strain construction method, a spinosad heterologous expression strain obtained by the method and use thereof in preparing the spinosad heterologous expression strain. The method utilizes a ...  
WO/2016/076102A1
[Problem] To provide a method for serum-free culture of human cartilage cells and a serum-free culture medium. [Solution] A method for serum-free culture of cartilage cells, said method comprising: an enzymatic treatment step for treatin...  
WO/2016/074624A1
Compositions and methods for increasing yield in a plant and for identifying, selecting and/or producing a plant having increased yield under non-water stress conditions.  
WO/2016/077720A1
The technology relates to monoclonal antibodies useful in detecting and / or treating cancer. In some embodiments, binding agents with specificity for at least one tumor antigen and T cell receptors (e.g., human CD3) are provided. In som...  
WO/2016/075687A2
The present invention provides attenuated or inactivated pathogenic bacteria having anti-cancer properties, compositions comprising the bacteria, and use thereof for treating cancers of the urogenital system.  
WO/2016/076282A1
The present invention develops and provides a technique for reducing environmental impact and saccharifying a plant biomass, especially a lignocellulosic biomass, efficiently in fewer steps in order to efficiently and effectively take ad...  
WO/2016/075314A1
The invention relates to novel transcription factors in oleaginous yeast, in particular Yarrowia lipolytica, as well as to expression cassettes that allow overexpression of said transcription factors. The invention also relates to the us...  
WO/2016/073739A1
The present invention is directed to methods and materials for producing recombinant viruses. In particular, methods and materials are provided for producing recombinant viruses in eukaryotic microalgae such as Chlamydomonas reinhardtii....  
WO/2016/073079A2
Methods and strategies for introducing genetic safeguards into microorganisms, genetically modified organisms (GMO) including the safeguards, and methods of use thereof are provided. The genetic safeguards generally impart a low escape f...  
WO/2016/072655A1
The cassia seed lactic acid bacteria fermented product of the present invention has been used for a long time and thus is highly safe; is a herb medicine having low possibility of causing side effects; and exhibits an effect of increasin...  
WO/2016/070258A1
The present invention provides technical solutions for the production of second generation fuels based on plant biomass conversion, for example from cell wall polymers. The present invention describes, inter alia, a genetically modified ...  
WO/2016/071570A1
The present description is related to the field of cultivating algae. It introduces a method of cultivating algae by depleting the culture of an inorganic nutrient and exposing the alga to high intensity light to obtain algal cell mass h...  
WO/2016/073585A1
General secretory pathway (GSP) mutant Listeria bacteria are provided. Aspects of the bacteria include the presence of a GSP mutation, e.g., a SecY and/or SecA mutation. Also provided are methods of making and using the Listeria bacteria...  
WO/2016/072563A1
The present invention provides: a method capable of increasing the production of lipid by culturing diploid microalgae Chlamydomonas sp., obtained by treating haploid wild-type microalgae Chlamydomonas sp. with colcemid; a method for pro...  
WO/2016/070814A1
Provided is a high-stability T cell receptor (TCR). The TCR comprises (i) the whole or a part of TCRα chain except a transmembrane domain thereof, and (ii) the whole or a part of TCRβ chain except a transmembrane domain thereof, both t...  
WO/2016/072448A1
Provided is an endoxylanase mutant having improved thermal stability. An endoxylanase mutant having endoxylanase activity and including an amino acid sequence in which one or more amino acid residues selected from positions corresponding...  
WO/2016/071707A1
The present invention resides in a method for the manufacture of a disulphide- requiring biopharmaceutical having an element of at least tertiary structure using wild type E. coli.  
WO/2016/070849A1
Provided in the present invention are a class of Lincomycin biosynthetic intermediates and a preparation method and use thereof. Specifically provided are Lincomycin biosynthetic intermediates obtained from the genetic modification of a ...  
WO/2016/073353A1
Embodiments disclose an apparatus and methods for biological sample processing enabling isolation and enrichment of microbial or pathogenic constituents from the sample. A vessel for sample containment and extraction is further disclosed...  
WO/2016/073364A1
A method and immunogenic composition for blocking transmission of a Plasmodium species via an Anopheles species. The immunogenic composition, containing a Fibrinogen-Related Protein 1 (FREP1) protein and/or an immunogenic portion thereof...  
WO/2016/069345A1
The invention generally provides a sample preparation vessel including a flexible substrate defining at least one sealable opening adapted and configured to receive a solid sample; at least one fitting; and at least one filter adjacent t...  
WO/2016/068266A1
The present invention provides a cell culture substrate which includes a nanofiber, made of a biodegradable polymer, on a support made of a biodegradable polymer. Further, provided is a cell culture method which is characterized by perfo...  
WO/2016/070160A1
The invention provides methods and systems for the production of lipid products from a gaseous substrate using a two stage fermentation process. The method comprises providing a gaseous substrate comprising CO, CO2 or H2 or mixtures ther...  
WO/2016/066260A1
The present invention provides methods for the non-covalent surface display of proteins of interest (POI), in particular for Fc-domain containing proteins such as antibodies. The inventive method may be used to screen and select proteins...  
WO/2016/065698A1
Provided are a saccharomyces cerevisiae strain CCTCC M 2014463 capable of being co-fermented by multiple carbon sources and an application thereof. The strain can adopt glucose, galactose, xylose, allulose, cane sugar, maltose, melibiose...  
WO/2016/068249A1
A cell isolation method comprises: a cell trapping step of allowing a solution of interest to pass through a cell trapping filter having multiple through-holes formed therein as observed in the thickness direction, thereby trapping isola...  
WO/2016/069432A1
The present invention relates to isolated or purified asporogenous Bacillus megaterium (B. megaterium) strains comprising a B. megaterium genome, wherein said genome is modified in that the spo0A gene is deleted or functionally deleted a...  

Matches 51 - 100 out of 89,145